海翔药业
(002099)
| 流通市值：80.18亿 | | | 总市值：80.29亿 |
| 流通股本：16.17亿 | | | 总股本：16.19亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,476,603,702.63 | 1,488,185,947.95 | 1,596,168,996.4 | 1,420,570,794.77 |
| 应收票据及应收账款 | 368,435,006.58 | 471,863,478.32 | 477,138,467.57 | 424,703,017.66 |
| 应收账款 | 368,435,006.58 | 471,863,478.32 | 477,138,467.57 | 424,703,017.66 |
| 应收款项融资 | 21,637,257.75 | 19,838,878.44 | 26,916,514.39 | 20,437,512.26 |
| 预付款项 | 53,713,839.74 | 29,634,366 | 38,986,801.14 | 22,283,130.66 |
| 其他应收款合计 | 11,483,114.71 | 10,665,128.64 | 10,659,415.3 | 10,303,311.92 |
| 存货 | 800,680,210.22 | 724,050,424.58 | 636,368,872.33 | 702,270,769.4 |
| 其他流动资产 | 41,816,789.07 | 30,397,594.64 | 30,895,062.37 | 25,166,241.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,775,226,104.05 | 2,839,434,160.58 | 2,817,134,129.5 | 2,625,734,777.97 |
| 非流动资产: | | | | |
| 长期股权投资 | 159,741,558.17 | 161,534,639.57 | 162,798,249.49 | 166,672,282.37 |
| 其他权益工具投资 | 23,680,709.25 | 23,680,709.25 | 23,680,709.25 | 23,680,709.25 |
| 其他非流动金融资产 | 481,319,980.6 | 481,319,980.6 | 481,319,980.6 | 481,319,980.6 |
| 投资性房地产 | 5,831,548.09 | 6,114,464.05 | 6,397,380.01 | 6,680,295.97 |
| 固定资产 | 2,430,890,751.62 | 2,503,194,797.69 | 2,513,410,268.18 | 2,641,270,666.74 |
| 在建工程 | 552,199,663.53 | 430,245,958.9 | 450,071,882.16 | 372,911,115.22 |
| 使用权资产 | 11,267,825.31 | 12,877,024.85 | 14,072,278.63 | 15,129,550.48 |
| 无形资产 | 525,369,225.41 | 529,737,726.85 | 533,588,314.07 | 520,796,104.25 |
| 商誉 | 603,314,115.69 | 603,314,115.69 | 603,314,115.69 | 603,314,115.69 |
| 长期待摊费用 | 3,402,411.91 | 3,303,580.09 | 3,890,907.21 | 4,039,344.99 |
| 递延所得税资产 | 37,686,966.53 | 37,309,122.54 | 40,753,949.63 | 41,574,009.59 |
| 其他非流动资产 | - | - | - | 16,970,000 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,834,704,756.11 | 4,792,632,120.08 | 4,833,298,034.92 | 4,894,358,175.15 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,609,930,860.16 | 7,632,066,280.66 | 7,650,432,164.42 | 7,520,092,953.12 |
| 流动负债: | | | | |
| 短期借款 | 1,094,868,055.55 | 1,165,686,416.67 | 1,213,912,825 | 1,028,832,828.61 |
| 交易性金融负债 | 7,083,613.52 | 2,682,000 | 2,682,000 | 36,370,389.61 |
| 应付票据及应付账款 | 829,643,402.57 | 694,703,042.94 | 552,949,597.34 | 603,339,324.27 |
| 其中：应付票据 | 239,998,846.96 | 61,475,326 | 3,102,550 | 35,858,493.37 |
| 应付账款 | 589,644,555.61 | 633,227,716.94 | 549,847,047.34 | 567,480,830.9 |
| 合同负债 | 12,352,732.19 | 14,539,581.24 | 15,216,884.26 | 10,133,522.96 |
| 应付职工薪酬 | 40,646,874.86 | 38,389,289.64 | 51,157,302.82 | 50,089,884.41 |
| 应交税费 | 20,894,850.43 | 26,174,990.53 | 16,815,798.44 | 27,088,206.79 |
| 其他应付款合计 | 33,186,233.65 | 37,805,678.98 | 37,614,352.22 | 35,316,681.58 |
| 应付股利 | 2,051,370.43 | 2,051,370.43 | 2,051,370.43 | 2,051,370.43 |
| 一年内到期的非流动负债 | 14,199,934.06 | 14,199,934.06 | 5,374,817.06 | 14,474,549.84 |
| 其他流动负债 | 1,179,332.36 | 1,881,461.4 | 1,318,400.91 | 1,182,960.96 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,054,055,029.19 | 1,996,062,395.46 | 1,897,041,978.05 | 1,806,828,349.03 |
| 非流动负债: | | | | |
| 长期借款 | - | 50,000,000 | 110,000,000 | - |
| 租赁负债 | 7,852,910.05 | 8,463,712.25 | 10,188,516.57 | 10,209,948.95 |
| 预计负债 | 2,661,686.02 | 2,661,686.02 | 2,661,686.02 | 2,677,030.18 |
| 递延收益 | 53,383,680.94 | 53,432,884.92 | 56,123,643 | 57,314,501.25 |
| 递延所得税负债 | 31,442,134.1 | 34,425,775.89 | 37,973,537.47 | 41,342,364.53 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 95,340,411.11 | 148,984,059.08 | 216,947,383.06 | 111,543,844.91 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,149,395,440.3 | 2,145,046,454.54 | 2,113,989,361.11 | 1,918,372,193.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,618,715,253 | 1,618,715,253 | 1,618,715,253 | 1,618,715,253 |
| 资本公积 | 2,906,279,032.74 | 2,906,279,032.74 | 2,906,279,032.74 | 2,906,279,032.74 |
| 减:库存股 | 151,419,651.94 | 151,419,651.94 | 97,375,760.01 | - |
| 其他综合收益 | 1,951,474.33 | 1,951,474.33 | 1,951,474.33 | 1,951,474.33 |
| 盈余公积 | 262,906,627.77 | 262,906,627.77 | 262,906,627.77 | 262,906,627.77 |
| 未分配利润 | 828,479,667.18 | 854,602,405.94 | 849,093,249.08 | 816,499,910.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,466,912,403.08 | 5,493,035,141.84 | 5,541,569,876.91 | 5,606,352,298.36 |
| 少数股东权益 | -6,376,983.22 | -6,015,315.72 | -5,127,073.6 | -4,631,539.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,460,535,419.86 | 5,487,019,826.12 | 5,536,442,803.31 | 5,601,720,759.18 |
| 负债和股东权益合计 | 7,609,930,860.16 | 7,632,066,280.66 | 7,650,432,164.42 | 7,520,092,953.12 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |